Suppr超能文献

鼻窦肠型腺癌的内镜手术与外切除术比较

Comparison of endoscopic and external resections for sinonasal instestinal-type adenocarcinoma.

作者信息

Mortuaire Geoffrey, Leroy Xavier, Vandenhende-Szymanski Claire, Chevalier Dominique, Thisse Anne-Sophie

机构信息

Otorhinolaryngology-Head and Neck Surgery Department, University Hospital, Lille, France.

Université de Lille 2, Lille, France.

出版信息

Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4343-4350. doi: 10.1007/s00405-016-4181-4. Epub 2016 Jun 30.

Abstract

Endoscopic sinus surgery (ESS) is considered as a valid option in the management of nasal adenocarcinoma (ADC). Comparative studies with open approaches are still required. A monocentric retrospective study was carried out from May 2002 to December 2013, including 43 patients with intestinal-type adenocarcinoma of the ethmoid sinus. Non-resectable tumours or recurrences were excluded. Before 2008, open approach with lateral rhinotomy (LR) was performed as the gold standard of treatment. From 2008, ESS was systematically used as a first-line option as long as a complete resection was achievable. Adjuvant radiation therapy was delivered (RT) for all the patients. LR and ESS were performed in, respectively, 23 and 20 patients. The two groups were comparable in terms of age, occupational dust exposure, histopathological subtypes, and T stage based on the pathological assessment of the specimen (10 pT2, 26 pT3, 2 pT4a, and 5 pT4b). The tumour origin was mainly located in the olfactory cleft with the involvement of the cribriform plate in 60 % of patients. No major complication was observed in ESS group with a reduced hospital stay (5.6 vs 7.6 days). The disease-free survival was not different between LR and ESS groups over a mean follow-up period of 6.6 years. Even for local advanced stages with skull base involvement, we confirm the reliability and the advantages of ESS in terms of oncological outcomes and morbidity. We advocate complete excision of the olfactory cleft to ensure an appropriate control of the tumoral origin.

摘要

内镜鼻窦手术(ESS)被认为是治疗鼻腺癌(ADC)的一种有效选择。仍需要与开放手术方法进行比较研究。我们于2002年5月至2013年12月开展了一项单中心回顾性研究,纳入43例筛窦肠型腺癌患者。排除不可切除肿瘤或复发肿瘤患者。2008年前,采用外侧鼻切开术(LR)的开放手术作为治疗的金标准。从2008年起,只要能实现完整切除,ESS就被系统地用作一线选择。所有患者均接受辅助放疗(RT)。分别有23例和20例患者接受了LR和ESS手术。根据标本的病理评估,两组在年龄、职业粉尘暴露、组织病理学亚型和T分期方面具有可比性(10例pT2、26例pT3、2例pT4a和5例pT4b)。肿瘤起源主要位于嗅裂,60%的患者筛板受累。ESS组未观察到严重并发症,住院时间缩短(5.6天对7.6天)。在平均6.6年的随访期内,LR组和ESS组的无病生存率无差异。即使对于累及颅底的局部晚期病例,我们也证实了ESS在肿瘤学结局和发病率方面的可靠性和优势。我们主张完整切除嗅裂以确保对肿瘤起源进行适当控制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验